Global Alopecia Market Overview :
Global Alopecia market is estimated to reach $12.3 Billion by 2025; growing at a CAGR of 5.6% till 2025. Alopecia causes hair loss on the scalp or body. Depression, hormonal imbalance, hypertension, and aging are the main factors causing alopecia. This disease is found in about 5% of the population. In this disease, the immune system attacks hair follicles and results in sudden hair loss. Alopecia can affect anyone regardless of gender and age. The disease type is categorized as Alopecia areata, Cicatricial alopecia, Traction alopecia, Alopecia totalis, Alopecia Universalis, Androgenetic alopecia, and Others. The precautions for alopecia are to protect hair from the sun by wearing caps, hats & scarves and wear sunscreen if exposed to the sun. Moreover, it is not contagious.
Global Alopecia Market: Growth Factors
The factors driving the market growth are deskbound lifestyle, unhealthy lifestyle, escalation in cancer patients, and hormonal imbalance. However, side effects related to alopecia treatment such as uncombable hair syndrome might hinder the market growth. Rising awareness about hair treatment and rise in expenditure for aesthetic appearance might act as an opportunity in the coming years.
Global Alopecia Market: Segmentation
The market is segmented mainly segmented on the basis of disease type, end use, sales channel, and gender. Based on disease type, the market is categorized as alopecia areata, cicatricial alopecia, traction alopecia, alopecia totalis, Alopecia Universalis, androgenetic alopecia, and others. On the basis of end users, the market is divided into dermatology clinics and homecare setting. Based on the sales channel, the market is segmented into prescription and OTC. On the basis of gender, the market is categorized as male and female.
Global Alopecia Market: Regional Analysis
Based on geography, the global alopecia market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America is further segmented as U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is divided into India, China, Japan, South Korea, and Rest of Asia-Pacific while RoW is divided into South America, the Middle East, and Africa
Global Alopecia Market: Competitive Players
Key players operating in the market include Cipla, Inc., Johnson & Johnson Services, Inc., Sun Pharmaceuticals Industries Ltd., Lexington Intl., LLC, Merck & Co., Inc, Cirrus Hair Centers, Transitions Hair, Vita-Cos-Med Klett-Loch GmbH, Capillus, and Follica, Inc.
Alopecia Market Key Segments:
By Disease Type
- Alopecia areata
- Cicatricial Alopecia
- Traction alopecia
- Alopecia totalis
- Alopecia Universalis
- Androgenetic alopecia
By End Use
- Dermatology clinics
- Homecare setting
By Sales Channel
- North America
- The U.S.
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Rest of the World
- South America
- Middle East
Key Market Players
- Cipla, Inc.
- Johnson & Johnson Services, Inc.
- Sun Pharmaceuticals Industries Ltd.
- Lexington Intl., LLC
- Merck & Co., Inc
- Cirrus Hair Centers
- Transitions Hair
- Vita-Cos-Med Klett-Loch GmbH
- Follica, Inc.
What Report Provides
- Full in-depth analysis of the parent market
- Important changes in market dynamics
- Segmentation details of the market
- Former, on-going, and projected market analysis in terms of volume and value
- Assessment of niche industry developments
- Market share analysis
- Key strategies of major players
- Emerging segments and regional markets
- Testimonials to companies in order to fortify their foothold in the market